Biostatistical Issues and the Design of Type 1 Diabetes TrialNet : NIDDK

Biostatistical Issues and the Design of Type 1 Diabetes TrialNet

March 7, 2005,
Bethesda, MD

Summary

This meeting will convene experts in the areas of biostatistics, endocrinology, and clinical trials to discuss creative approaches to protocol design so that multiple trials can successfully be performed concurrently and rigorously within the TrialNet network

Agenda

Monday, March 7, 2005 8:00 a.m. - 4:00 a.m.
Bethesda Marriott Suites,
Moderators: Jim Neaton and Desmond Schatz

Introduction

7:30 a.m. - 8:00 a.m.
Sign-In and Light Refreshments
 
8:00 a.m. - 8:15 a.m. Meeting Goals: What We Hope To Accomplish Des Schatz
 
8:15 a.m. - 8:30 a.m. Where We Are
  • mission of TrialNet
  • number of sites
  • potential patient base
  • screening effort required for trials
  • natural history (description of T1DM pathogenesis) and measurement of ?-cell function
  • issues in prevention studies, early onset studies, and studies of patients with long history of T1DM
  • current TrialNet studies

Jay Skyler 
 
Design Issues in Clinical Trials

8:30 a.m. - 9:10 a.m. Surrogate Endpoints: The Challenges Are Greater Than They Seem (10-minute discussion) Tom Fleming
 
9:10 a.m. - 9:50 a.m.
Some Phase 23 Designs (10-minute discussion) Peter Thall
 
9:50 a.m. - 10:20 a.m. What About the Effect Size? (10-minute discussion) Jeff Mahon
 
10:20 a.m. - 10:30 a.m. Break

10:30 a.m. - 11:00 a.m. Discussion of Fleming, Thall, and Mahon Butch Tsiatis

11:00 a.m. - 12:00 noon Panel Discussion Tom Fleming, John Lachin, Jeff Mahon, Dave Reboussin, Rich Simon, Peter Thall, Butch Tsiatis

12:00 noon - 1:00 p.m. *Lunch* (On Your Own)

TrialNet Design Issues

1:00 p.m. - 1:30 p.m. POPPI 1 Study as an Example
 (15 minute each) Mark Espeland, Joan Hilton, Tom Louis Panel and

General Discussion Mark Espeland, Carla Greenbaum, Joan Hilton, John Lachin, Tiepu Liu, Tom Louis, Jeff Mahon, Jerry Palmer, Des Schatz, Jay Skyler

Summary
 
3:30 p.m. - 4:00 p.m. Meeting Summary Herman Mitchell Final Comments Des Schatz

4:00 p.m. Adjournment Return to top

Contact Information

Ellen Leschek, M.D. 
Type 1 Diabetes TrialNet Program
Health of Institutes National Diseases Kidney and Digestive Diabetes Institute
Email: lescheke@extra.niddk.nih.gov
Phone301-435-6047 or 301-480-3503
Bethesda MD 

Page last updated: May 05, 2008

General inquiries may be addressed to: Office of Communications & Public Liaison
NIDDK, NIH
Building 31. Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
USA
For information about NIDDK programs: 301.496.3583

The National Institutes of Health   Department of Health and Human Services   USA.gov is the U.S. government's official web portal to all federal, state, and local government web resources and services.  HONcode Seal - Link to the Health on the Net Foundation